nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—RARB—lung cancer	0.501	0.865	CbGaD
Acitretin—ALB—lung cancer	0.0782	0.135	CbGaD
Acitretin—ALB—Gefitinib—lung cancer	0.0289	0.415	CbGbCtD
Acitretin—ALB—Erlotinib—lung cancer	0.0171	0.246	CbGbCtD
Acitretin—ALB—Irinotecan—lung cancer	0.0154	0.222	CbGbCtD
Acitretin—ALB—Methotrexate—lung cancer	0.00816	0.117	CbGbCtD
Acitretin—CYP26A1—bronchus—lung cancer	0.00363	0.0944	CbGeAlD
Acitretin—CYP26A1—trachea—lung cancer	0.00326	0.0848	CbGeAlD
Acitretin—RARA—mammary gland—lung cancer	0.0028	0.073	CbGeAlD
Acitretin—RBP1—respiratory system—lung cancer	0.00263	0.0685	CbGeAlD
Acitretin—RARB—respiratory system—lung cancer	0.00244	0.0634	CbGeAlD
Acitretin—RBP1—epithelium—lung cancer	0.0022	0.0573	CbGeAlD
Acitretin—RARB—bronchus—lung cancer	0.00201	0.0522	CbGeAlD
Acitretin—RARG—respiratory system—lung cancer	0.00199	0.0517	CbGeAlD
Acitretin—RARA—respiratory system—lung cancer	0.00187	0.0486	CbGeAlD
Acitretin—RBP1—cardiac atrium—lung cancer	0.00183	0.0476	CbGeAlD
Acitretin—Isotretinoin—RARB—lung cancer	0.00173	0.326	CrCbGaD
Acitretin—ALB—mammary gland—lung cancer	0.00158	0.0411	CbGeAlD
Acitretin—RXRB—cardiac atrium—lung cancer	0.00155	0.0404	CbGeAlD
Acitretin—Alitretinoin—RARB—lung cancer	0.00141	0.266	CrCbGaD
Acitretin—RBP1—lung—lung cancer	0.0014	0.0364	CbGeAlD
Acitretin—RARB—lung—lung cancer	0.00129	0.0337	CbGeAlD
Acitretin—RXRB—lung—lung cancer	0.00119	0.0309	CbGeAlD
Acitretin—RARA—bone marrow—lung cancer	0.0011	0.0285	CbGeAlD
Acitretin—RARG—lung—lung cancer	0.00106	0.0275	CbGeAlD
Acitretin—RARA—lung—lung cancer	0.000992	0.0258	CbGeAlD
Acitretin—Tretinoin—RARB—lung cancer	0.000992	0.187	CrCbGaD
Acitretin—RBP1—lymph node—lung cancer	0.000956	0.0249	CbGeAlD
Acitretin—RARB—lymph node—lung cancer	0.000885	0.023	CbGeAlD
Acitretin—RARG—lymph node—lung cancer	0.000722	0.0188	CbGeAlD
Acitretin—RARA—lymph node—lung cancer	0.000679	0.0177	CbGeAlD
Acitretin—Tretinoin—CYP2A6—lung cancer	0.000397	0.0749	CrCbGaD
Acitretin—ALB—lymph node—lung cancer	0.000383	0.00995	CbGeAlD
Acitretin—Vitamin A—CYP1A1—lung cancer	0.000288	0.0543	CrCbGaD
Acitretin—Tretinoin—CYP1A1—lung cancer	0.000278	0.0525	CrCbGaD
Acitretin—Alitretinoin—ABCB1—lung cancer	0.00021	0.0396	CrCbGaD
Acitretin—Decreased appetite—Cisplatin—lung cancer	6.27e-05	0.000354	CcSEcCtD
Acitretin—Hyperhidrosis—Paclitaxel—lung cancer	6.26e-05	0.000354	CcSEcCtD
Acitretin—Gastrointestinal disorder—Cisplatin—lung cancer	6.23e-05	0.000352	CcSEcCtD
Acitretin—Depression—Methotrexate—lung cancer	6.19e-05	0.000349	CcSEcCtD
Acitretin—Anorexia—Paclitaxel—lung cancer	6.18e-05	0.000349	CcSEcCtD
Acitretin—Gastritis—Doxorubicin—lung cancer	6.17e-05	0.000348	CcSEcCtD
Acitretin—Pain—Cisplatin—lung cancer	6.17e-05	0.000348	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Doxorubicin—lung cancer	6.15e-05	0.000347	CcSEcCtD
Acitretin—Muscular weakness—Doxorubicin—lung cancer	6.15e-05	0.000347	CcSEcCtD
Acitretin—Vomiting—Vinorelbine—lung cancer	6.12e-05	0.000346	CcSEcCtD
Acitretin—Body temperature increased—Gemcitabine—lung cancer	6.12e-05	0.000345	CcSEcCtD
Acitretin—Rash—Vinorelbine—lung cancer	6.07e-05	0.000343	CcSEcCtD
Acitretin—Dermatitis—Vinorelbine—lung cancer	6.07e-05	0.000343	CcSEcCtD
Acitretin—Stomatitis—Methotrexate—lung cancer	6.05e-05	0.000341	CcSEcCtD
Acitretin—Headache—Vinorelbine—lung cancer	6.03e-05	0.000341	CcSEcCtD
Acitretin—Conjunctivitis—Methotrexate—lung cancer	6.03e-05	0.000341	CcSEcCtD
Acitretin—Feeling abnormal—Cisplatin—lung cancer	5.94e-05	0.000336	CcSEcCtD
Acitretin—Paraesthesia—Etoposide—lung cancer	5.93e-05	0.000335	CcSEcCtD
Acitretin—Haematuria—Methotrexate—lung cancer	5.92e-05	0.000334	CcSEcCtD
Acitretin—Pancreatitis—Doxorubicin—lung cancer	5.91e-05	0.000334	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Paclitaxel—lung cancer	5.9e-05	0.000333	CcSEcCtD
Acitretin—Somnolence—Etoposide—lung cancer	5.87e-05	0.000332	CcSEcCtD
Acitretin—Cough—Docetaxel—lung cancer	5.87e-05	0.000331	CcSEcCtD
Acitretin—Insomnia—Paclitaxel—lung cancer	5.86e-05	0.000331	CcSEcCtD
Acitretin—Epistaxis—Methotrexate—lung cancer	5.85e-05	0.00033	CcSEcCtD
Acitretin—Hypersensitivity—Irinotecan—lung cancer	5.85e-05	0.00033	CcSEcCtD
Acitretin—Paraesthesia—Paclitaxel—lung cancer	5.82e-05	0.000328	CcSEcCtD
Acitretin—Somnolence—Paclitaxel—lung cancer	5.76e-05	0.000325	CcSEcCtD
Acitretin—Decreased appetite—Etoposide—lung cancer	5.74e-05	0.000324	CcSEcCtD
Acitretin—Chest pain—Docetaxel—lung cancer	5.73e-05	0.000323	CcSEcCtD
Acitretin—Arthralgia—Docetaxel—lung cancer	5.73e-05	0.000323	CcSEcCtD
Acitretin—Myalgia—Docetaxel—lung cancer	5.73e-05	0.000323	CcSEcCtD
Acitretin—Pancytopenia—Doxorubicin—lung cancer	5.72e-05	0.000323	CcSEcCtD
Acitretin—Nausea—Vinorelbine—lung cancer	5.72e-05	0.000323	CcSEcCtD
Acitretin—Gastrointestinal disorder—Etoposide—lung cancer	5.71e-05	0.000322	CcSEcCtD
Acitretin—Dyspepsia—Paclitaxel—lung cancer	5.7e-05	0.000322	CcSEcCtD
Acitretin—Body temperature increased—Cisplatin—lung cancer	5.7e-05	0.000322	CcSEcCtD
Acitretin—Asthenia—Irinotecan—lung cancer	5.7e-05	0.000322	CcSEcCtD
Acitretin—Fatigue—Etoposide—lung cancer	5.7e-05	0.000322	CcSEcCtD
Acitretin—Constipation—Etoposide—lung cancer	5.65e-05	0.000319	CcSEcCtD
Acitretin—Pain—Etoposide—lung cancer	5.65e-05	0.000319	CcSEcCtD
Acitretin—Dysuria—Doxorubicin—lung cancer	5.64e-05	0.000318	CcSEcCtD
Acitretin—Decreased appetite—Paclitaxel—lung cancer	5.63e-05	0.000318	CcSEcCtD
Acitretin—Dry mouth—Docetaxel—lung cancer	5.6e-05	0.000316	CcSEcCtD
Acitretin—Haemoglobin—Methotrexate—lung cancer	5.6e-05	0.000316	CcSEcCtD
Acitretin—Gastrointestinal disorder—Paclitaxel—lung cancer	5.59e-05	0.000316	CcSEcCtD
Acitretin—Fatigue—Paclitaxel—lung cancer	5.59e-05	0.000315	CcSEcCtD
Acitretin—Haemorrhage—Methotrexate—lung cancer	5.57e-05	0.000314	CcSEcCtD
Acitretin—Hepatitis—Methotrexate—lung cancer	5.57e-05	0.000314	CcSEcCtD
Acitretin—Asthenia—Gemcitabine—lung cancer	5.55e-05	0.000313	CcSEcCtD
Acitretin—Constipation—Paclitaxel—lung cancer	5.54e-05	0.000313	CcSEcCtD
Acitretin—Pain—Paclitaxel—lung cancer	5.54e-05	0.000313	CcSEcCtD
Acitretin—Pharyngitis—Methotrexate—lung cancer	5.53e-05	0.000312	CcSEcCtD
Acitretin—Photosensitivity reaction—Doxorubicin—lung cancer	5.5e-05	0.000311	CcSEcCtD
Acitretin—Oedema—Docetaxel—lung cancer	5.49e-05	0.00031	CcSEcCtD
Acitretin—Weight increased—Doxorubicin—lung cancer	5.49e-05	0.00031	CcSEcCtD
Acitretin—Pruritus—Gemcitabine—lung cancer	5.48e-05	0.000309	CcSEcCtD
Acitretin—Infection—Docetaxel—lung cancer	5.46e-05	0.000308	CcSEcCtD
Acitretin—Weight decreased—Doxorubicin—lung cancer	5.45e-05	0.000308	CcSEcCtD
Acitretin—Feeling abnormal—Etoposide—lung cancer	5.45e-05	0.000307	CcSEcCtD
Acitretin—Diarrhoea—Irinotecan—lung cancer	5.44e-05	0.000307	CcSEcCtD
Acitretin—Gastrointestinal pain—Etoposide—lung cancer	5.4e-05	0.000305	CcSEcCtD
Acitretin—Visual impairment—Methotrexate—lung cancer	5.37e-05	0.000303	CcSEcCtD
Acitretin—Feeling abnormal—Paclitaxel—lung cancer	5.34e-05	0.000301	CcSEcCtD
Acitretin—Skin disorder—Docetaxel—lung cancer	5.33e-05	0.000301	CcSEcCtD
Acitretin—Hypersensitivity—Cisplatin—lung cancer	5.31e-05	0.0003	CcSEcCtD
Acitretin—Gastrointestinal pain—Paclitaxel—lung cancer	5.3e-05	0.000299	CcSEcCtD
Acitretin—Diarrhoea—Gemcitabine—lung cancer	5.3e-05	0.000299	CcSEcCtD
Acitretin—Neuropathy peripheral—Doxorubicin—lung cancer	5.27e-05	0.000297	CcSEcCtD
Acitretin—Dizziness—Irinotecan—lung cancer	5.25e-05	0.000297	CcSEcCtD
Acitretin—Urticaria—Etoposide—lung cancer	5.25e-05	0.000296	CcSEcCtD
Acitretin—Stomatitis—Doxorubicin—lung cancer	5.24e-05	0.000296	CcSEcCtD
Acitretin—Jaundice—Doxorubicin—lung cancer	5.24e-05	0.000296	CcSEcCtD
Acitretin—Anorexia—Docetaxel—lung cancer	5.24e-05	0.000295	CcSEcCtD
Acitretin—Abdominal pain—Etoposide—lung cancer	5.22e-05	0.000295	CcSEcCtD
Acitretin—Body temperature increased—Etoposide—lung cancer	5.22e-05	0.000295	CcSEcCtD
Acitretin—Urinary tract infection—Doxorubicin—lung cancer	5.22e-05	0.000295	CcSEcCtD
Acitretin—Conjunctivitis—Doxorubicin—lung cancer	5.22e-05	0.000295	CcSEcCtD
Acitretin—Eye disorder—Methotrexate—lung cancer	5.21e-05	0.000294	CcSEcCtD
Acitretin—Tinnitus—Methotrexate—lung cancer	5.19e-05	0.000293	CcSEcCtD
Acitretin—Asthenia—Cisplatin—lung cancer	5.18e-05	0.000292	CcSEcCtD
Acitretin—Urticaria—Paclitaxel—lung cancer	5.15e-05	0.000291	CcSEcCtD
Acitretin—Haematuria—Doxorubicin—lung cancer	5.12e-05	0.000289	CcSEcCtD
Acitretin—Abdominal pain—Paclitaxel—lung cancer	5.12e-05	0.000289	CcSEcCtD
Acitretin—Body temperature increased—Paclitaxel—lung cancer	5.12e-05	0.000289	CcSEcCtD
Acitretin—Epistaxis—Doxorubicin—lung cancer	5.07e-05	0.000286	CcSEcCtD
Acitretin—Angiopathy—Methotrexate—lung cancer	5.06e-05	0.000285	CcSEcCtD
Acitretin—Vomiting—Irinotecan—lung cancer	5.05e-05	0.000285	CcSEcCtD
Acitretin—Sinusitis—Doxorubicin—lung cancer	5.04e-05	0.000285	CcSEcCtD
Acitretin—Immune system disorder—Methotrexate—lung cancer	5.03e-05	0.000284	CcSEcCtD
Acitretin—Rash—Irinotecan—lung cancer	5.01e-05	0.000283	CcSEcCtD
Acitretin—Dermatitis—Irinotecan—lung cancer	5e-05	0.000282	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Docetaxel—lung cancer	5e-05	0.000282	CcSEcCtD
Acitretin—Chills—Methotrexate—lung cancer	5e-05	0.000282	CcSEcCtD
Acitretin—Headache—Irinotecan—lung cancer	4.98e-05	0.000281	CcSEcCtD
Acitretin—Insomnia—Docetaxel—lung cancer	4.97e-05	0.00028	CcSEcCtD
Acitretin—Diarrhoea—Cisplatin—lung cancer	4.94e-05	0.000279	CcSEcCtD
Acitretin—Paraesthesia—Docetaxel—lung cancer	4.93e-05	0.000278	CcSEcCtD
Acitretin—Alopecia—Methotrexate—lung cancer	4.92e-05	0.000278	CcSEcCtD
Acitretin—Vomiting—Gemcitabine—lung cancer	4.92e-05	0.000278	CcSEcCtD
Acitretin—Somnolence—Docetaxel—lung cancer	4.88e-05	0.000276	CcSEcCtD
Acitretin—Rash—Gemcitabine—lung cancer	4.88e-05	0.000275	CcSEcCtD
Acitretin—Dermatitis—Gemcitabine—lung cancer	4.88e-05	0.000275	CcSEcCtD
Acitretin—Hypersensitivity—Etoposide—lung cancer	4.87e-05	0.000275	CcSEcCtD
Acitretin—Erythema—Methotrexate—lung cancer	4.85e-05	0.000274	CcSEcCtD
Acitretin—Haemoglobin—Doxorubicin—lung cancer	4.85e-05	0.000274	CcSEcCtD
Acitretin—Headache—Gemcitabine—lung cancer	4.85e-05	0.000274	CcSEcCtD
Acitretin—Rhinitis—Doxorubicin—lung cancer	4.84e-05	0.000273	CcSEcCtD
Acitretin—Dyspepsia—Docetaxel—lung cancer	4.83e-05	0.000273	CcSEcCtD
Acitretin—Hepatitis—Doxorubicin—lung cancer	4.82e-05	0.000272	CcSEcCtD
Acitretin—Haemorrhage—Doxorubicin—lung cancer	4.82e-05	0.000272	CcSEcCtD
Acitretin—Hypoaesthesia—Doxorubicin—lung cancer	4.8e-05	0.000271	CcSEcCtD
Acitretin—Pharyngitis—Doxorubicin—lung cancer	4.79e-05	0.00027	CcSEcCtD
Acitretin—Decreased appetite—Docetaxel—lung cancer	4.77e-05	0.000269	CcSEcCtD
Acitretin—Hypersensitivity—Paclitaxel—lung cancer	4.77e-05	0.000269	CcSEcCtD
Acitretin—Oedema peripheral—Doxorubicin—lung cancer	4.75e-05	0.000268	CcSEcCtD
Acitretin—Dysgeusia—Methotrexate—lung cancer	4.75e-05	0.000268	CcSEcCtD
Acitretin—Gastrointestinal disorder—Docetaxel—lung cancer	4.74e-05	0.000268	CcSEcCtD
Acitretin—Asthenia—Etoposide—lung cancer	4.74e-05	0.000268	CcSEcCtD
Acitretin—Fatigue—Docetaxel—lung cancer	4.74e-05	0.000267	CcSEcCtD
Acitretin—Nausea—Irinotecan—lung cancer	4.72e-05	0.000266	CcSEcCtD
Acitretin—Constipation—Docetaxel—lung cancer	4.7e-05	0.000265	CcSEcCtD
Acitretin—Pain—Docetaxel—lung cancer	4.7e-05	0.000265	CcSEcCtD
Acitretin—Back pain—Methotrexate—lung cancer	4.69e-05	0.000265	CcSEcCtD
Acitretin—Pruritus—Etoposide—lung cancer	4.68e-05	0.000264	CcSEcCtD
Acitretin—Visual impairment—Doxorubicin—lung cancer	4.65e-05	0.000262	CcSEcCtD
Acitretin—Asthenia—Paclitaxel—lung cancer	4.65e-05	0.000262	CcSEcCtD
Acitretin—Nausea—Gemcitabine—lung cancer	4.6e-05	0.000259	CcSEcCtD
Acitretin—Vomiting—Cisplatin—lung cancer	4.59e-05	0.000259	CcSEcCtD
Acitretin—Pruritus—Paclitaxel—lung cancer	4.58e-05	0.000259	CcSEcCtD
Acitretin—Vision blurred—Methotrexate—lung cancer	4.57e-05	0.000258	CcSEcCtD
Acitretin—Rash—Cisplatin—lung cancer	4.55e-05	0.000257	CcSEcCtD
Acitretin—Dermatitis—Cisplatin—lung cancer	4.54e-05	0.000256	CcSEcCtD
Acitretin—Feeling abnormal—Docetaxel—lung cancer	4.53e-05	0.000255	CcSEcCtD
Acitretin—Diarrhoea—Etoposide—lung cancer	4.52e-05	0.000255	CcSEcCtD
Acitretin—Eye disorder—Doxorubicin—lung cancer	4.51e-05	0.000254	CcSEcCtD
Acitretin—Ill-defined disorder—Methotrexate—lung cancer	4.5e-05	0.000254	CcSEcCtD
Acitretin—Tinnitus—Doxorubicin—lung cancer	4.5e-05	0.000254	CcSEcCtD
Acitretin—Gastrointestinal pain—Docetaxel—lung cancer	4.49e-05	0.000253	CcSEcCtD
Acitretin—Flushing—Doxorubicin—lung cancer	4.48e-05	0.000253	CcSEcCtD
Acitretin—Diarrhoea—Paclitaxel—lung cancer	4.43e-05	0.00025	CcSEcCtD
Acitretin—Angiopathy—Doxorubicin—lung cancer	4.38e-05	0.000247	CcSEcCtD
Acitretin—Malaise—Methotrexate—lung cancer	4.37e-05	0.000247	CcSEcCtD
Acitretin—Dizziness—Etoposide—lung cancer	4.37e-05	0.000247	CcSEcCtD
Acitretin—Immune system disorder—Doxorubicin—lung cancer	4.36e-05	0.000246	CcSEcCtD
Acitretin—Abdominal pain—Docetaxel—lung cancer	4.34e-05	0.000245	CcSEcCtD
Acitretin—Body temperature increased—Docetaxel—lung cancer	4.34e-05	0.000245	CcSEcCtD
Acitretin—Chills—Doxorubicin—lung cancer	4.33e-05	0.000244	CcSEcCtD
Acitretin—Dizziness—Paclitaxel—lung cancer	4.28e-05	0.000242	CcSEcCtD
Acitretin—Nausea—Cisplatin—lung cancer	4.28e-05	0.000242	CcSEcCtD
Acitretin—Alopecia—Doxorubicin—lung cancer	4.26e-05	0.000241	CcSEcCtD
Acitretin—Cough—Methotrexate—lung cancer	4.23e-05	0.000239	CcSEcCtD
Acitretin—Vomiting—Etoposide—lung cancer	4.2e-05	0.000237	CcSEcCtD
Acitretin—Erythema—Doxorubicin—lung cancer	4.2e-05	0.000237	CcSEcCtD
Acitretin—Rash—Etoposide—lung cancer	4.17e-05	0.000235	CcSEcCtD
Acitretin—Dermatitis—Etoposide—lung cancer	4.16e-05	0.000235	CcSEcCtD
Acitretin—Headache—Etoposide—lung cancer	4.14e-05	0.000234	CcSEcCtD
Acitretin—Chest pain—Methotrexate—lung cancer	4.13e-05	0.000233	CcSEcCtD
Acitretin—Myalgia—Methotrexate—lung cancer	4.13e-05	0.000233	CcSEcCtD
Acitretin—Arthralgia—Methotrexate—lung cancer	4.13e-05	0.000233	CcSEcCtD
Acitretin—Tension—Doxorubicin—lung cancer	4.12e-05	0.000233	CcSEcCtD
Acitretin—Vomiting—Paclitaxel—lung cancer	4.12e-05	0.000233	CcSEcCtD
Acitretin—Dysgeusia—Doxorubicin—lung cancer	4.11e-05	0.000232	CcSEcCtD
Acitretin—Rash—Paclitaxel—lung cancer	4.09e-05	0.000231	CcSEcCtD
Acitretin—Dermatitis—Paclitaxel—lung cancer	4.08e-05	0.00023	CcSEcCtD
Acitretin—Discomfort—Methotrexate—lung cancer	4.08e-05	0.00023	CcSEcCtD
Acitretin—Nervousness—Doxorubicin—lung cancer	4.08e-05	0.00023	CcSEcCtD
Acitretin—Back pain—Doxorubicin—lung cancer	4.06e-05	0.000229	CcSEcCtD
Acitretin—Headache—Paclitaxel—lung cancer	4.06e-05	0.000229	CcSEcCtD
Acitretin—Hypersensitivity—Docetaxel—lung cancer	4.05e-05	0.000228	CcSEcCtD
Acitretin—Muscle spasms—Doxorubicin—lung cancer	4.04e-05	0.000228	CcSEcCtD
Acitretin—Vision blurred—Doxorubicin—lung cancer	3.96e-05	0.000223	CcSEcCtD
Acitretin—Asthenia—Docetaxel—lung cancer	3.94e-05	0.000222	CcSEcCtD
Acitretin—Infection—Methotrexate—lung cancer	3.93e-05	0.000222	CcSEcCtD
Acitretin—Nausea—Etoposide—lung cancer	3.93e-05	0.000222	CcSEcCtD
Acitretin—Ill-defined disorder—Doxorubicin—lung cancer	3.9e-05	0.00022	CcSEcCtD
Acitretin—Pruritus—Docetaxel—lung cancer	3.89e-05	0.000219	CcSEcCtD
Acitretin—Nausea—Paclitaxel—lung cancer	3.85e-05	0.000217	CcSEcCtD
Acitretin—Skin disorder—Methotrexate—lung cancer	3.84e-05	0.000217	CcSEcCtD
Acitretin—Hyperhidrosis—Methotrexate—lung cancer	3.83e-05	0.000216	CcSEcCtD
Acitretin—Malaise—Doxorubicin—lung cancer	3.79e-05	0.000214	CcSEcCtD
Acitretin—Anorexia—Methotrexate—lung cancer	3.77e-05	0.000213	CcSEcCtD
Acitretin—Diarrhoea—Docetaxel—lung cancer	3.76e-05	0.000212	CcSEcCtD
Acitretin—Cough—Doxorubicin—lung cancer	3.66e-05	0.000207	CcSEcCtD
Acitretin—Dizziness—Docetaxel—lung cancer	3.63e-05	0.000205	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Methotrexate—lung cancer	3.61e-05	0.000204	CcSEcCtD
Acitretin—Insomnia—Methotrexate—lung cancer	3.58e-05	0.000202	CcSEcCtD
Acitretin—Myalgia—Doxorubicin—lung cancer	3.58e-05	0.000202	CcSEcCtD
Acitretin—Arthralgia—Doxorubicin—lung cancer	3.58e-05	0.000202	CcSEcCtD
Acitretin—Chest pain—Doxorubicin—lung cancer	3.58e-05	0.000202	CcSEcCtD
Acitretin—Anxiety—Doxorubicin—lung cancer	3.56e-05	0.000201	CcSEcCtD
Acitretin—Paraesthesia—Methotrexate—lung cancer	3.55e-05	0.000201	CcSEcCtD
Acitretin—Discomfort—Doxorubicin—lung cancer	3.53e-05	0.000199	CcSEcCtD
Acitretin—Somnolence—Methotrexate—lung cancer	3.52e-05	0.000199	CcSEcCtD
Acitretin—Dry mouth—Doxorubicin—lung cancer	3.5e-05	0.000197	CcSEcCtD
Acitretin—Vomiting—Docetaxel—lung cancer	3.49e-05	0.000197	CcSEcCtD
Acitretin—Dyspepsia—Methotrexate—lung cancer	3.48e-05	0.000197	CcSEcCtD
Acitretin—Rash—Docetaxel—lung cancer	3.46e-05	0.000195	CcSEcCtD
Acitretin—Dermatitis—Docetaxel—lung cancer	3.46e-05	0.000195	CcSEcCtD
Acitretin—Decreased appetite—Methotrexate—lung cancer	3.44e-05	0.000194	CcSEcCtD
Acitretin—Headache—Docetaxel—lung cancer	3.44e-05	0.000194	CcSEcCtD
Acitretin—Oedema—Doxorubicin—lung cancer	3.43e-05	0.000193	CcSEcCtD
Acitretin—Gastrointestinal disorder—Methotrexate—lung cancer	3.42e-05	0.000193	CcSEcCtD
Acitretin—Fatigue—Methotrexate—lung cancer	3.41e-05	0.000193	CcSEcCtD
Acitretin—Infection—Doxorubicin—lung cancer	3.41e-05	0.000192	CcSEcCtD
Acitretin—Pain—Methotrexate—lung cancer	3.38e-05	0.000191	CcSEcCtD
Acitretin—Skin disorder—Doxorubicin—lung cancer	3.33e-05	0.000188	CcSEcCtD
Acitretin—Hyperhidrosis—Doxorubicin—lung cancer	3.31e-05	0.000187	CcSEcCtD
Acitretin—Anorexia—Doxorubicin—lung cancer	3.27e-05	0.000184	CcSEcCtD
Acitretin—Nausea—Docetaxel—lung cancer	3.26e-05	0.000184	CcSEcCtD
Acitretin—Feeling abnormal—Methotrexate—lung cancer	3.26e-05	0.000184	CcSEcCtD
Acitretin—Gastrointestinal pain—Methotrexate—lung cancer	3.24e-05	0.000183	CcSEcCtD
Acitretin—Urticaria—Methotrexate—lung cancer	3.14e-05	0.000177	CcSEcCtD
Acitretin—Body temperature increased—Methotrexate—lung cancer	3.13e-05	0.000177	CcSEcCtD
Acitretin—Abdominal pain—Methotrexate—lung cancer	3.13e-05	0.000177	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.12e-05	0.000176	CcSEcCtD
Acitretin—Insomnia—Doxorubicin—lung cancer	3.1e-05	0.000175	CcSEcCtD
Acitretin—Paraesthesia—Doxorubicin—lung cancer	3.08e-05	0.000174	CcSEcCtD
Acitretin—Somnolence—Doxorubicin—lung cancer	3.05e-05	0.000172	CcSEcCtD
Acitretin—Dyspepsia—Doxorubicin—lung cancer	3.02e-05	0.00017	CcSEcCtD
Acitretin—Decreased appetite—Doxorubicin—lung cancer	2.98e-05	0.000168	CcSEcCtD
Acitretin—Gastrointestinal disorder—Doxorubicin—lung cancer	2.96e-05	0.000167	CcSEcCtD
Acitretin—Fatigue—Doxorubicin—lung cancer	2.96e-05	0.000167	CcSEcCtD
Acitretin—Constipation—Doxorubicin—lung cancer	2.93e-05	0.000165	CcSEcCtD
Acitretin—Pain—Doxorubicin—lung cancer	2.93e-05	0.000165	CcSEcCtD
Acitretin—Hypersensitivity—Methotrexate—lung cancer	2.92e-05	0.000165	CcSEcCtD
Acitretin—Asthenia—Methotrexate—lung cancer	2.84e-05	0.00016	CcSEcCtD
Acitretin—Feeling abnormal—Doxorubicin—lung cancer	2.82e-05	0.000159	CcSEcCtD
Acitretin—Gastrointestinal pain—Doxorubicin—lung cancer	2.8e-05	0.000158	CcSEcCtD
Acitretin—Pruritus—Methotrexate—lung cancer	2.8e-05	0.000158	CcSEcCtD
Acitretin—Urticaria—Doxorubicin—lung cancer	2.72e-05	0.000154	CcSEcCtD
Acitretin—Body temperature increased—Doxorubicin—lung cancer	2.71e-05	0.000153	CcSEcCtD
Acitretin—Abdominal pain—Doxorubicin—lung cancer	2.71e-05	0.000153	CcSEcCtD
Acitretin—Diarrhoea—Methotrexate—lung cancer	2.71e-05	0.000153	CcSEcCtD
Acitretin—Dizziness—Methotrexate—lung cancer	2.62e-05	0.000148	CcSEcCtD
Acitretin—Hypersensitivity—Doxorubicin—lung cancer	2.53e-05	0.000143	CcSEcCtD
Acitretin—Vomiting—Methotrexate—lung cancer	2.52e-05	0.000142	CcSEcCtD
Acitretin—Rash—Methotrexate—lung cancer	2.5e-05	0.000141	CcSEcCtD
Acitretin—Dermatitis—Methotrexate—lung cancer	2.49e-05	0.000141	CcSEcCtD
Acitretin—Headache—Methotrexate—lung cancer	2.48e-05	0.00014	CcSEcCtD
Acitretin—Asthenia—Doxorubicin—lung cancer	2.46e-05	0.000139	CcSEcCtD
Acitretin—Pruritus—Doxorubicin—lung cancer	2.43e-05	0.000137	CcSEcCtD
Acitretin—Nausea—Methotrexate—lung cancer	2.35e-05	0.000133	CcSEcCtD
Acitretin—Diarrhoea—Doxorubicin—lung cancer	2.35e-05	0.000132	CcSEcCtD
Acitretin—Dizziness—Doxorubicin—lung cancer	2.27e-05	0.000128	CcSEcCtD
Acitretin—Vomiting—Doxorubicin—lung cancer	2.18e-05	0.000123	CcSEcCtD
Acitretin—Rash—Doxorubicin—lung cancer	2.16e-05	0.000122	CcSEcCtD
Acitretin—Dermatitis—Doxorubicin—lung cancer	2.16e-05	0.000122	CcSEcCtD
Acitretin—Headache—Doxorubicin—lung cancer	2.15e-05	0.000121	CcSEcCtD
Acitretin—Nausea—Doxorubicin—lung cancer	2.04e-05	0.000115	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.76e-05	0.000134	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CD—lung cancer	1.76e-05	0.000134	CbGpPWpGaD
Acitretin—RBP1—Disease—SRC—lung cancer	1.75e-05	0.000134	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—GNG11—lung cancer	1.74e-05	0.000133	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—APOA1—lung cancer	1.73e-05	0.000132	CbGpPWpGaD
Acitretin—RARB—Gene Expression—CREBBP—lung cancer	1.73e-05	0.000132	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—IL6—lung cancer	1.72e-05	0.000131	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NOTCH3—lung cancer	1.71e-05	0.000131	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CD—lung cancer	1.71e-05	0.000131	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ALDOA—lung cancer	1.7e-05	0.00013	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	1.69e-05	0.000129	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—APOA1—lung cancer	1.69e-05	0.000129	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—ALB—lung cancer	1.69e-05	0.000129	CbGpPWpGaD
Acitretin—RBP1—Disease—STAT3—lung cancer	1.69e-05	0.000129	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—IL6R—lung cancer	1.69e-05	0.000129	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CREBBP—lung cancer	1.69e-05	0.000129	CbGpPWpGaD
Acitretin—RBP1—Disease—NRAS—lung cancer	1.68e-05	0.000129	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TF—lung cancer	1.68e-05	0.000128	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—CREBBP—lung cancer	1.65e-05	0.000126	CbGpPWpGaD
Acitretin—RARA—Gene Expression—CREBBP—lung cancer	1.65e-05	0.000126	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NCOA3—lung cancer	1.65e-05	0.000126	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IRF1—lung cancer	1.64e-05	0.000126	CbGpPWpGaD
Acitretin—ALB—Metabolism—PLBD1—lung cancer	1.64e-05	0.000125	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.62e-05	0.000124	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—JUNB—lung cancer	1.62e-05	0.000124	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	1.61e-05	0.000123	CbGpPWpGaD
Acitretin—RBP1—Disease—MAPK3—lung cancer	1.61e-05	0.000123	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MMP2—lung cancer	1.61e-05	0.000123	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MAP2K1—lung cancer	1.61e-05	0.000123	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ADCY1—lung cancer	1.61e-05	0.000123	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ABCG2—lung cancer	1.61e-05	0.000123	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CG—lung cancer	1.58e-05	0.000121	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ENO2—lung cancer	1.58e-05	0.00012	CbGpPWpGaD
Acitretin—RXRA—Metabolism—HPGDS—lung cancer	1.58e-05	0.00012	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MDM2—lung cancer	1.57e-05	0.00012	CbGpPWpGaD
Acitretin—RBP1—Disease—MYC—lung cancer	1.57e-05	0.00012	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—RAF1—lung cancer	1.57e-05	0.00012	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPP2R1B—lung cancer	1.57e-05	0.00012	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ABCG2—lung cancer	1.56e-05	0.00012	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ADCY1—lung cancer	1.56e-05	0.00012	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—EGF—lung cancer	1.56e-05	0.000119	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—ERBB2—lung cancer	1.55e-05	0.000118	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.55e-05	0.000118	CbGpPWpGaD
Acitretin—RBP1—Disease—EGFR—lung cancer	1.53e-05	0.000117	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MTOR—lung cancer	1.53e-05	0.000117	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CB—lung cancer	1.53e-05	0.000117	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTT1—lung cancer	1.53e-05	0.000117	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP2A6—lung cancer	1.51e-05	0.000115	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GCLC—lung cancer	1.51e-05	0.000115	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.5e-05	0.000115	CbGpPWpGaD
Acitretin—ALB—Metabolism—HSD17B10—lung cancer	1.5e-05	0.000115	CbGpPWpGaD
Acitretin—ALB—Hemostasis—APP—lung cancer	1.5e-05	0.000114	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CB—lung cancer	1.49e-05	0.000114	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.48e-05	0.000113	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTGS2—lung cancer	1.48e-05	0.000113	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CXCL8—lung cancer	1.47e-05	0.000112	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—TF—lung cancer	1.45e-05	0.000111	CbGpPWpGaD
Acitretin—RBP1—Disease—KRAS—lung cancer	1.45e-05	0.000111	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ENO1—lung cancer	1.43e-05	0.000109	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—CREBBP—lung cancer	1.43e-05	0.000109	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.43e-05	0.000109	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—RAF1—lung cancer	1.43e-05	0.000109	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—ERBB2—lung cancer	1.41e-05	0.000108	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.41e-05	0.000108	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CASP3—lung cancer	1.41e-05	0.000108	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL2—lung cancer	1.41e-05	0.000107	CbGpPWpGaD
Acitretin—ALB—Metabolism—CKB—lung cancer	1.4e-05	0.000107	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CD—lung cancer	1.39e-05	0.000106	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCND1—lung cancer	1.37e-05	0.000105	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—JUN—lung cancer	1.37e-05	0.000104	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—IL6—lung cancer	1.36e-05	0.000104	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—ALB—lung cancer	1.34e-05	0.000102	CbGpPWpGaD
Acitretin—RBP1—Disease—PIK3CA—lung cancer	1.33e-05	0.000102	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MMP9—lung cancer	1.33e-05	0.000102	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CDKN1A—lung cancer	1.33e-05	0.000101	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTEN—lung cancer	1.32e-05	0.000101	CbGpPWpGaD
Acitretin—ALB—Metabolism—CNDP2—lung cancer	1.31e-05	0.0001	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTM2—lung cancer	1.31e-05	0.0001	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTEN—lung cancer	1.29e-05	9.85e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP2E1—lung cancer	1.28e-05	9.82e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—MTMR3—lung cancer	1.28e-05	9.75e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NQO1—lung cancer	1.27e-05	9.71e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EP300—lung cancer	1.26e-05	9.64e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.24e-05	9.51e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PGAM1—lung cancer	1.24e-05	9.5e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—RAF1—lung cancer	1.24e-05	9.46e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.23e-05	9.42e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—HRAS—lung cancer	1.23e-05	9.42e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—EP300—lung cancer	1.23e-05	9.39e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SRC—lung cancer	1.23e-05	9.37e-05	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—RAF1—lung cancer	1.21e-05	9.26e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MMP9—lung cancer	1.21e-05	9.25e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CB—lung cancer	1.21e-05	9.24e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ITGB1—lung cancer	1.2e-05	9.15e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—lung cancer	1.19e-05	9.13e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP2A7—lung cancer	1.19e-05	9.07e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—STAT3—lung cancer	1.18e-05	9.04e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NRAS—lung cancer	1.18e-05	9.01e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—IL6—lung cancer	1.18e-05	9.01e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—ERCC2—lung cancer	1.18e-05	9e-05	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MAPK3—lung cancer	1.17e-05	8.97e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SDC4—lung cancer	1.16e-05	8.87e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EP300—lung cancer	1.15e-05	8.77e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—STK11—lung cancer	1.14e-05	8.75e-05	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MYC—lung cancer	1.14e-05	8.72e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MAPK3—lung cancer	1.13e-05	8.63e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—SRC—lung cancer	1.12e-05	8.53e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IL2—lung cancer	1.11e-05	8.48e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MYC—lung cancer	1.1e-05	8.4e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—AKT1—lung cancer	1.09e-05	8.32e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—VEGFA—lung cancer	1.09e-05	8.31e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—STAT3—lung cancer	1.08e-05	8.23e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.07e-05	8.21e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EGFR—lung cancer	1.07e-05	8.21e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NRAS—lung cancer	1.07e-05	8.21e-05	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MAPK3—lung cancer	1.07e-05	8.2e-05	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—MYC—lung cancer	1.06e-05	8.12e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTP1—lung cancer	1.06e-05	8.1e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—RRM1—lung cancer	1.06e-05	8.08e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTA3—lung cancer	1.06e-05	8.08e-05	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MAPK3—lung cancer	1.05e-05	8.04e-05	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MYC—lung cancer	1.04e-05	7.98e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CAT—lung cancer	1.03e-05	7.88e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MAPK3—lung cancer	1.03e-05	7.86e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.02e-05	7.83e-05	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MYC—lung cancer	1.02e-05	7.82e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KRAS—lung cancer	1.02e-05	7.76e-05	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MAPK3—lung cancer	1.01e-05	7.71e-05	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MAPK3—lung cancer	1.01e-05	7.71e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—AVP—lung cancer	1.01e-05	7.71e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ABCB1—lung cancer	1e-05	7.66e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—B4GALT5—lung cancer	9.94e-06	7.6e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—TYMS—lung cancer	9.85e-06	7.53e-05	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MYC—lung cancer	9.82e-06	7.5e-05	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MYC—lung cancer	9.82e-06	7.5e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EGFR—lung cancer	9.78e-06	7.48e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ABCB1—lung cancer	9.77e-06	7.46e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTM1—lung cancer	9.74e-06	7.44e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—SRC—lung cancer	9.69e-06	7.4e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTA4—lung cancer	9.67e-06	7.39e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	9.45e-06	7.22e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—lung cancer	9.44e-06	7.21e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTA2—lung cancer	9.42e-06	7.2e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CA—lung cancer	9.33e-06	7.13e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—MMP1—lung cancer	9.31e-06	7.12e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KRAS—lung cancer	9.24e-06	7.06e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP1A1—lung cancer	9.23e-06	7.05e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ERCC2—lung cancer	9.15e-06	7e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CA—lung cancer	9.09e-06	6.95e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTA1—lung cancer	9.09e-06	6.95e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—lung cancer	9.02e-06	6.9e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ABCC3—lung cancer	8.99e-06	6.87e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—MAPK3—lung cancer	8.93e-06	6.82e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—APOA1—lung cancer	8.91e-06	6.81e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKR1C1—lung cancer	8.71e-06	6.65e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HRAS—lung cancer	8.63e-06	6.59e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—CREBBP—lung cancer	8.62e-06	6.59e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—UGT1A1—lung cancer	8.45e-06	6.46e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL6—lung cancer	8.26e-06	6.31e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GNG11—lung cancer	8.15e-06	6.23e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CG—lung cancer	8.13e-06	6.22e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—APOA1—lung cancer	8.11e-06	6.2e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—EGF—lung cancer	8.04e-06	6.14e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—APOA1—lung cancer	7.92e-06	6.05e-05	CbGpPWpGaD
Acitretin—RARG—Gene Expression—AKT1—lung cancer	7.92e-06	6.05e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—HRAS—lung cancer	7.85e-06	6e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ALDOA—lung cancer	7.76e-06	5.93e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	7.71e-06	5.89e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKT1—lung cancer	7.62e-06	5.82e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.58e-06	5.79e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CREBBP—lung cancer	7.54e-06	5.76e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NCOA3—lung cancer	7.53e-06	5.76e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—IL6—lung cancer	7.52e-06	5.75e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—AKT1—lung cancer	7.43e-06	5.68e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	7.4e-06	5.66e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	7.37e-06	5.63e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ADCY1—lung cancer	7.33e-06	5.6e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ABCG2—lung cancer	7.33e-06	5.6e-05	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—AKT1—lung cancer	7.24e-06	5.53e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CG—lung cancer	7.23e-06	5.52e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HPGDS—lung cancer	7.19e-06	5.49e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ENO2—lung cancer	7.19e-06	5.49e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CD—lung cancer	7.15e-06	5.46e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPP2R1B—lung cancer	7.14e-06	5.46e-05	CbGpPWpGaD
Acitretin—RARB—Gene Expression—AKT1—lung cancer	7.1e-06	5.43e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	7.05e-06	5.39e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTT1—lung cancer	6.97e-06	5.33e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—AKT1—lung cancer	6.94e-06	5.3e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP2A6—lung cancer	6.89e-06	5.27e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GCLC—lung cancer	6.89e-06	5.27e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—POMC—lung cancer	6.88e-06	5.26e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.86e-06	5.25e-05	CbGpPWpGaD
Acitretin—RARA—Gene Expression—AKT1—lung cancer	6.81e-06	5.2e-05	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—AKT1—lung cancer	6.81e-06	5.2e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CREBBP—lung cancer	6.7e-06	5.12e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ENO1—lung cancer	6.53e-06	4.99e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	6.53e-06	4.99e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.51e-06	4.97e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—RAF1—lung cancer	6.38e-06	4.88e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CD—lung cancer	6.35e-06	4.86e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ALB—lung cancer	6.27e-06	4.79e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CB—lung cancer	6.23e-06	4.76e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	6.02e-06	4.6e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP2E1—lung cancer	5.86e-06	4.48e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NQO1—lung cancer	5.79e-06	4.43e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IL2—lung cancer	5.72e-06	4.37e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.67e-06	4.34e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.62e-06	4.3e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CB—lung cancer	5.54e-06	4.23e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	5.52e-06	4.22e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS2—lung cancer	5.49e-06	4.19e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MAPK3—lung cancer	5.26e-06	4.02e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—STK11—lung cancer	5.22e-06	3.99e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—EP300—lung cancer	5.14e-06	3.92e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MYC—lung cancer	5.12e-06	3.91e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SRC—lung cancer	4.99e-06	3.82e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.9e-06	3.75e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—lung cancer	4.86e-06	3.72e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTP1—lung cancer	4.83e-06	3.69e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NRAS—lung cancer	4.8e-06	3.67e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTEN—lung cancer	4.79e-06	3.66e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CAT—lung cancer	4.7e-06	3.59e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.67e-06	3.57e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—MAPK3—lung cancer	4.6e-06	3.52e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ABCB1—lung cancer	4.57e-06	3.5e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—EP300—lung cancer	4.56e-06	3.49e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—TYMS—lung cancer	4.49e-06	3.43e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTM1—lung cancer	4.44e-06	3.39e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP1A1—lung cancer	4.21e-06	3.22e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ERCC2—lung cancer	4.17e-06	3.19e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KRAS—lung cancer	4.13e-06	3.16e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CA—lung cancer	3.8e-06	2.9e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—lung cancer	3.67e-06	2.81e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—APOA1—lung cancer	3.61e-06	2.76e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—AKT1—lung cancer	3.55e-06	2.71e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HRAS—lung cancer	3.51e-06	2.69e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.46e-06	2.64e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CA—lung cancer	3.38e-06	2.58e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CG—lung cancer	3.3e-06	2.52e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—POMC—lung cancer	3.14e-06	2.4e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—AKT1—lung cancer	3.1e-06	2.37e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CREBBP—lung cancer	3.06e-06	2.34e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CD—lung cancer	2.9e-06	2.22e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKT1—lung cancer	2.76e-06	2.11e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CB—lung cancer	2.53e-06	1.93e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS2—lung cancer	2.5e-06	1.91e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTEN—lung cancer	2.18e-06	1.67e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—EP300—lung cancer	2.08e-06	1.59e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CA—lung cancer	1.54e-06	1.18e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKT1—lung cancer	1.26e-06	9.62e-06	CbGpPWpGaD
